324 related articles for article (PubMed ID: 26014226)
21. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
22. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
23. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
[TBL] [Abstract][Full Text] [Related]
24. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
25. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
26. Plasma microRNAs serve as potential biomarkers for abdominal aortic aneurysm.
Zhang W; Shang T; Huang C; Yu T; Liu C; Qiao T; Huang D; Liu Z; Liu C
Clin Biochem; 2015 Oct; 48(15):988-92. PubMed ID: 25916817
[TBL] [Abstract][Full Text] [Related]
27. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
Wang C; Hu J; Lu M; Gu H; Zhou X; Chen X; Zen K; Zhang CY; Zhang T; Ge J; Wang J; Zhang C
Sci Rep; 2015 Jan; 5():7610. PubMed ID: 25556603
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
30. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
31. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
[TBL] [Abstract][Full Text] [Related]
32. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
[TBL] [Abstract][Full Text] [Related]
33. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.
Yin X; Zheng X; Liu M; Wang D; Sun H; Qiu Y; Chen J; Shi B
Cell Biol Int; 2020 Apr; 44(4):958-965. PubMed ID: 31872468
[TBL] [Abstract][Full Text] [Related]
35. Plasma microRNA profiles for bladder cancer detection.
Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
[TBL] [Abstract][Full Text] [Related]
36. Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction.
Zhang R; Lan C; Pei H; Duan G; Huang L; Li L
BMC Cardiovasc Disord; 2015 Jun; 15():51. PubMed ID: 26077801
[TBL] [Abstract][Full Text] [Related]
37. The association of circulating miR-30a, miR-29 and miR-133 with white-coat hypertension.
Huang YQ; Huang C; Chen JY; Li J; Feng YQ
Biomark Med; 2016 Dec; 10(12):1231-1239. PubMed ID: 27924640
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
Wang RJ; Zheng YH; Wang P; Zhang JZ
Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
40. A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
Shin VY; Ng EK; Chan VW; Kwong A; Chu KM
Mol Cancer; 2015 Nov; 14():202. PubMed ID: 26607322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
